Given that 36.5 percent of patients were carriers of government insurance and another 10.4 percent were uninsured in 2014, 19 further elucidating disparities between these groups is an essential step in eliminating them. The future of funding and availability of government-sponsored insurance plans is in question. 20 Any disparity in care may be amplified with an increasing number of patients enrolled in Medicaid and Medicare.
It is unknown whether insurance type affects the number of operative interventions a woman undergoes during her reconstructive course, or the likelihood that she will undergo nipple-areola reconstruction and areola tattooing. Our aim is to determine the independent effect of insurance type on the number of procedures, number of revisions, and the likelihood of nipple-areola reconstruction. Any discrepancies in breast reconstruction based on insurance status should be explored further to ensure the highest quality of care and equal treatment of all patients in our health care system.
PATIENTS AND METHODS
After approval by the institutional review board (no. 201308013), a retrospective cohort study was created using the billing database for procedures on all patients with private insurance, Medicare, or Medicaid who had undergone breast reconstruction at our institution among January of 1999 (the year the Women's Health and Cancer Rights Act was enacted) and January of 2016. Patients initiating reconstruction after January of 2015 were excluded, as the majority had not completed their reconstructive pathway. In addition, patients who did not initiate their reconstruction at our institution or had reconstruction for nononcologic reasons were excluded. Codes for initial reconstruction, revision procedures, and nipple reconstruction were queried to create a reconstructive timeline for each patient. The following information was gathered: age, race, cancer stage, date of surgery, procedure, diagnosis, and health insurance type. Procedures were then coded by type-initial reconstruction, revision procedures, symmetry procedures, nipple reconstruction, and areola tattooing (Table 1) . Operative intervention for immediate complications within the 90 days of the initial operation stay such as flap loss or hematoma were not counted in the analysis, as these are urgent and necessary procedures that are not performed to achieve symmetry or restoration of the appearance of normal anatomy. Furthermore, code 11970 for implant exchange alone was counted in the total number of procedures, but not toward revision procedures, because it is a necessary step in removing a temporary implant, rather than an elective revision.
Once the reconstructive timeline was created, patients were categorized by insurance type Table 1 . Operating room trips were counted by counting the total number of service dates for all Current Procedural Terminology codes. Patients missing key data were excluded from the study. Summary statistics were generated by means of established methods. Because of asymmetry and skewness, continuous sample distributions were summarized by using median and interquartile ranges. Given the central limit theorem, continuous sample distributions were compared by means of t test and categorical sample distributions by means of chi-square analyses, respectively. Analysis of covariance was used to determine the independent effect of insurance type on number of procedures, operating room trips, and revisions, whereas logistic regression was used to estimate the independent probability of undergoing a symmetry procedure, nipple reconstruction, or areola tattooing by insurance type. Both multivariate models included age, cancer stage, race, laterality of reconstruction (unilateral versus bilateral), and initial reconstruction type (implant-based, abdominal flap, latissimus flap, and other) as covariates. Analysis was completed using SAS 9.4 (SAS Institute, Inc., Cary, N.C.) and STATA v13.0 (StataCorp, College Station, Texas). Two-sided alpha = 0.05 indicated significance in all tests.
RESULTS
A total of 3113 patients were analyzed: 2271 (72.9 percent) patients had private insurance, 450 (14.5 percent) had Medicare, and 392 (12.6 percent) had Medicaid. Demographics and type of reconstruction by insurance category are listed in Table 2 . Average age was 50.2 years, and 38.6 percent of patients underwent bilateral reconstruction. There was a significant difference in age by insurance type (p < 0.01), with Medicare being the oldest at 59.2 ± 12.3 years and Medicaid the youngest at 45.9 ± 9.4 years. There was a significant difference in the distribution of race among insurance types (p < 0.01). Caucasian patients were the majority in all groups, constituting 85.6 percent of patients with private insurance, 77.3 percent of patients with Medicare, and 54.6 percent of patients with Medicaid. Cancer stage (p = 0.02) and percentage of bilateral reconstruction (p < 0.01) differed by insurance type, as did initial type of reconstruction (p = 0.01) ( Table 2 ). The rate of implant-based reconstruction ranged from 73.7 percent in privately insured patients to 81.6 percent in Medicare patients. There were 23 Plastic and Reconstructive Surgery • October 2017 plastic surgeons included in analysis; 11 of those performed breast reconstruction on more than 50 patients (Table 3) .
Total Number of Procedures by Billed Current Procedural Terminology Codes
As a whole, patients underwent a median of 3 reconstructive procedures (interquartile range, 2 to 5; mean, 3.8 reconstructive procedures). Initially, the unadjusted number of coded procedures differed among all insurance types (Fig. 1) . After adjusting for age, cancer stage, race, bilateral versus unilateral procedures, surgeon, and initial reconstructive type, private patients underwent 3.80 procedures, Medicare patients underwent 3.75 procedures, and Medicaid patients underwent 3.69 procedures. None of these differed significantly (Table 4) .
Trips to the Operating Room
Patients underwent a median of 3 trips to the operating or procedure room (interquartile range, 2 to 4; mean, 2.9 trips to the operating room). The number of trips to the operating room differed between privately insured and Medicare patients (p = 0.02) as shown in Figure 2 ; however, on controlled analysis as described above, there was no significant difference (Table 4) .
Total Number of Revision Procedures
Patients underwent a median of 1 revision procedure (interquartile range, 0 to 2; mean, 1.62 revision procedures) as described in Table 1 . Unadjusted revision rates did not differ among insurance type (Fig. 3) . There was no significant difference in number of revision procedures between private and Medicare patients (adjusted average, 1.86 versus 1.72 revision procedures; p = 0.5), or between private and Medicaid patients (adjusted average, 1.64 versus 1.52 revision procedures; p = 0.2) ( Table 4) .
Symmetry Procedures
Among patients who underwent unilateral breast reconstruction (n = 1913), 46 percent of patients underwent symmetry procedures on the contralateral breast (Figs. 4 and 5) . On both raw estimates and on controlled analysis, adjusting for age, cancer stage, race, and type of reconstruction, there were no differences by insurance type (Table 5) .
Nipple Reconstruction
Among patients who underwent skin-sparing mastectomy or a similar procedure in which the nipple-areola complex was removed, 41.6 percent underwent nipple reconstruction in either the operating room or the office setting. Unadjusted analysis revealed a significant difference in the likelihood of undergoing this procedure between privately insured and Medicare patients (OR, 0.66; p < 0.01). However, when controlling for covariates, there was no significant difference 
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between Medicare (OR, 0.77; p = 0.1) and Medicaid (OR, 0.89; p = 0.4) ( Table 5) .
Areolar Tattooing
Lastly, 30.1 percent of patients underwent areola tattooing to complete their reconstructive course. When comparing unadjusted probabilities of undergoing areola tattooing, privately insured patients were more likely to undergo the procedure than Medicare patients (p = 0.03). However, on controlled analysis, privately insured patients had a likelihood similar to that for Medicare (OR, 0.92; p = 0.6) and Medicaid patients (OR, 0.96; p = 0.8) of undergoing areola tattooing.
DISCUSSION
This study provides an analysis of the number of breast reconstructive procedures and revisions, and rates of symmetry procedures, nipple reconstruction, and tattooing by insurance types at a single large academic medical center. Although there are known differences in reconstructive preferences by age, level of education, and race, 8, 9, 12, [21] [22] [23] to our knowledge, this is the first study that focuses on payor type as an influence on the subsequent reconstructive pathway after index reconstruction, with the goal of highlighting any existing discrepancies in and attempt to control them. We examined a large cohort of patients who underwent reconstruction after the government mandated that reconstruction and symmetry procedures be covered by insurance in 1998. As the distribution of payor type shifts with the initiation of the Affordable Care Act and Medicaid expansion, it is important to highlight these issues to avoid inadvertent biases in care patterns.
It is reasonable to conclude from this information that patients with different insurance types receive similar care once they enter the reconstructive pathway. We did find differences in both disease stage and rates of bilateral reconstruction, similar to previously published literature. Differences in disease stage are likely attributable to racial differences among payor types, and it is known that nonwhite patients are more likely to present with later stage disease. [24] [25] [26] White patients and those with private insurance are also more likely to undergo contralateral prophylactic mastectomy, which may explain differences in rates of bilateral reconstruction. 27, 28 Statistical modeling shows us that on direct comparison, there appears to be a difference in subsequent revisions to achieve symmetry and a final aesthetic result. However on adjusted analysis, this appears to be a function of either patient background or the practice pattern of a given surgeon. There are a small number of patients who are driving the need for a greater number of revisions and overall procedures, which did lead to the skewed data shown in Figures 1 through 3 . However the histograms are similar among insurance types. Surgeons and patients each have a different view on what it means to obtain an "acceptable" result and likely have different thresholds for performing revision surgery. Acceptability may fall into a wide range of results, and this is based on very individual and personal happiness with results. We did have a high proportion of patients undergoing bilateral reconstruction (38.6 percent) when compared to some prior studies, which we attribute in part to the rise in contralateral prophylactic mastectomy that has been seen nationwide. 27 However, it is reassuring to report that there are no notable differences based on payor type alone.
In 2009, before initiation of the Affordable Care Act, Yang et al. used the National Impatient Sample database to characterize 35,217 women undergoing immediate breast reconstruction to look at reconstructive trends in immediate breast reconstruction and reported that women without private insurance were less likely to undergo immediate breast reconstruction compared with those with private insurance. 7 They attribute this primarily to patients' uncertainty that insurance will cover all procedures and differing care locations (safety-net hospitals versus other hospitals). Our patient population includes delayed reconstruction but has a similar breakdown of payor type. Similarly, our Medicaid group was significantly younger and had a larger proportion of nonwhite patients than those with private insurance. Medicare patients were older and were more likely to undergo implant-based reconstruction than Medicaid or privately insured patients in our study, which is likely attributable to patient age and risks of complications after autologous reconstruction in older women. 29, 30 Our study has several important limitations. First, because our study is retrospective, there 533e remains a strong possibility of known and unknown confounding, even though we controlled for a multitude of potential confounders in our multivariate analysis. Subjective measures such as patient or provider choice influencing reconstructive choices cannot be identified through a retrospective billing database and would require prospective, survey-based studies. However, it would be unethical to perform a prospective study, in which providers identified a disparity by insurance type and chose not to intervene. Second, other considerations for reconstruction that are not addressed in this study include travel distance, which was recently discussed by Roughton et al., 10 and level of education, each of which may impact choices. Third, this study was performed at a single academic center, which limits external validity. Our distribution of payors and overall patient population may not be generalizable to other geographic areas or to the private sector. Future research should aim for large, multi-institutional, and geographically widespread databases that aims to refute, confirm, or extend our principal findings. Furthermore, there is likely a subset of patients who initiated reconstruction at this institution yet chose to complete their revision procedures and nipple-areola reconstruction elsewhere. Because our facility accepts the broadest range of insurance plans in our region, this rate is likely low, but not possible to calculate. Our study demonstrates that once patients enter the reconstructive pathway, subsequent disparities in receiving subsequent revisions to achieve an optimal symmetric and cosmetic result are not a function of insurance type. We acknowledge that this may change with a fee-for-service payor model or in an incentive-based reimbursement system. Therefore, based on our current findings, future investigations should be twofold. First, further research should focus primarily on the referral of patients into the reconstructive pathway to achieve index reconstruction in the first place, as there are ongoing discrepancies in access to care, particularly in immediate reconstruction. 8, 9 Second, further research should also target either patient-or provider-based variables that can explain discrepancies observed after patients enter the reconstructive pathway. Such a study could compare patient-reported outcome scores at completion of reconstruction between patients with different insurance plans to explore which aspects of care along the reconstructive and revision pathway are patient motivated. It is possible that a larger multicenter database would provide further insight into disparities in the reconstructive pathway in multiple geographic locations with a larger pool of providers and patients to eliminate biases of our single-institution study.
CONCLUSIONS
Health care equity remains a critical cornerstone to optimize care for each patient regardless of insurance status, race, gender, location, and socioeconomic status. Our findings are reassuring that, within our institution, insurance type does not affect subsequent revision procedures to achieve an optimal, symmetric, cosmetic result. Instead, initial discrepancies observed may be a function of patient and/or provider decisions instead. This institution, like many other academic institutions in the readership, has a large population of patients insured through Medicare and Medicaid and serves as a safety-net hospital for women who cannot find care elsewhere. Future research and focus should target both variables that affect whether patients enter the reconstructive pathway (including insurance type) and these variables once patients achieve their index reconstruction. Whether this is done in the form of community outreach, the presence of clinics in medically underserved locations, or improving communication with breast oncologic surgeons, we should make every effort to provide equal care to all patients. 
